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Single nucleotide polymorphisms (SNPs) in the fat mass and obesity-associated (FTO) locus are associated with obesity, but
lifestyle factors maymodulate the obesity risk related to FTO.+is study examined the physical activity and dietary patterns of 528
physically active white men and women (mean (SD): 34.9 (9.5) years, 26.6 (4.3) kg·m−2) carrying di9erent risk variants of FTO
SNP rs9939609. Sex, age, and anthropometric measurements (stature, body mass, and waist circumference) were self-reported
using an online questionnaire, and body mass index and waist-to-height ratio were calculated. Physical activity and eating
behaviour were assessed using the International Physical Activity Questionnaire (IPAQ) and +ree-Factor Eating Questionnaire
(TFEQ), respectively. Body mass, body mass index (BMI), waist circumference, and waist-to-height ratio were not signiAcantly
di9erent between individuals expressing di9erent FTO rs9939609 risk variants (all P≥ 0.66). +e cohort was physically active
(4516 (3043) total METmin·week−1), although homozygous risk allele carriers (AA) displayed higher TFEQ cognitive restraint
compared with nonrisk allele carriers (TT) (ES� 0.33 and P � 0.03). In conclusion, obesity-related parameters were not di9erent
in physically active individuals expressing di9erent risk variants of FTO rs9939609, although homozygous risk allele carriers
exhibited higher cognitive restraint.
1. Introduction
Obesity is a major risk factor for several chronic diseases and
represents a major health and economic burden on society
[1]. +e aetiology of obesity is multifactorial and is inFu-
enced by complex interactions between environmental,
lifestyle, and genetic factors [2]. Consequently, it is im-
portant to understand the interplay between these factors
when designing strategies targeting the prevention of
obesity.
+e fat mass and obesity-associated gene (FTO) was the
Arst common variant identiAed by genome-wide association
studies that inFuences obesity risk [3]. Single nucleotide
polymorphisms (SNPs) in intron 1 of FTO have been
associated consistently with obesity risk across di9erent ages
and populations [4–9]. At FTO rs9939609 SNP, individuals
homozygous for the risk allele (AA) weigh 3 kg more and
have a 1.7-fold higher risk of obesity than those who do not
carry a risk allele (TT) [3]. Studies have examined the e9ect
of FTO variants on regulators of energy homeostasis to
elucidate the mechanisms inFuencing FTO-mediated obe-
sity risk. In this respect, evidence suggests that FTOmay play
a central role in the regulation of food intake [10, 11]. +is is
supported by studies demonstrating that individuals ho-
mozygous for the risk allele exhibit reduced satiety, poor
food choices, and increased energy consumption [12–14].
Conversely, FTO obesity SNPs have not been related to
energy expenditure, with evidence suggesting that those
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carrying the risk allele do not show reduced basal metabolic
rate [15] or physical activity levels [7, 16, 17].
Although the association between FTO and obesity risk
is well established, lifestyle maymodulate obesity risk related
to FTO. Several studies have suggested that FTO-mediated
body fatness may be attenuated in physically active in-
dividuals [18–20]. Indeed, a meta-analysis concluded that
higher physical activity levels attenuate the inFuence of FTO
variation on obesity risk by 30% [21], and exercise in-
terventions have demonstrated eIcacy in promoting weight
loss in FTO risk allele carriers [22, 23]. However, it is not well
understood how the body mass index- (BMI-) increasing
inFuence of FTO is attenuated in physically active in-
dividuals. An improved understanding of the di9erences in
dietary and physical activity patterns in variants of FTO
rs9939609 SNP within a physically active cohort may pro-
vide a greater insight into the behaviours that o9set FTO-
mediated obesity. +erefore, the aim of this study was to
examine physical activity and dietary habits in a sample of
physically active men and women carrying di9erent risk
variants of FTO rs9939609 SNP.
2. Materials and Methods
2.1. Participants. With the approval of Loughborough
University’s Ethical Advisory Committee, 708 men and
women (age 34.0 (±9.3) years; body mass 82.5 (±16.3) kg;
BMI 26.5 (±4.2) kg·m−2; waist circumference 84.4 (±11.0)
cm; and waist-to-height ratio 0.48 (±0.06)) were recruited
between March to November 2015 to participate in this
study. Participants were recruited through FitnessGenes Ltd.
(Bicester, Oxfordshire, UK—previously MuscleGenes Ltd.)
and were predominantly based in European countries or the
United States. Full informed consent, via an online consent
form, was obtained from participants before the study
commenced. Participants were volunteers from a customer
base that were known to be participating in a regular Atness
program but were not involved in elite sports. Participants
classiAed themselves into one of Afteen ethnic groups. To
reduce variability in the cohort, individuals who identiAed
themselves as non-mixed white descent (British, Irish, and
other White background) were included in this study (see
Supplementary Methods (available here) for ethnic back-
ground selection criteria). Of the 708 recruited, 1 had
missing genotype data, 17 had missing demographic or
anthropometric data, and 162 did not classify themselves as
non-mixed white descent. +erefore, results are presented
for 528 participants (421 males and 107 females). Participant
characteristics are presented in Table 1.
2.2. Genotype Analysis. Participant DNA was obtained from
saliva, which was collected via an Oragene DNA self-
collection kit (DNA Genotek Inc., Ottawa, ON, Canada)
Table 1: Participant characteristics.
Total (n� 528) Female (n� 107) Male (n� 421)
Age and anthropometric characteristics
Age (years) 34.9 (9.5) 36.8 (9.1) 34.5 (9.6)∗
Stature (cm) 176.5 (9.4) 164.9 (7.1) 179.5 (7.4)∗
Body mass (kg) 83.4 (16.5) 69.0 (13.9) 87.0 (15.0)∗
Body mass index (kg·m−2) 26.6 (4.3) 25.4 (4.8) 27.0 (4.0)∗
Waist circumference (cm) 84.6 (10.4) 78.2 (11.8) 86.2 (9.4)∗
Waist-to-height ratio 0.48 (0.06) 0.48 (0.07) 0.48 (0.05)
Central obesitya 37 (7%) 21 (20%) 16 (4%)∗∗
Physical activity levelsb
Vigorous MET (min·week−1) 2629 (1908) 2511 (1912) 2659 (1908)
Moderate MET (min·week−1) 737 (1026) 716 (874) 743 (1062)
Walking MET (min·week−1) 1150 (1269) 1284 (1374) 1115 (1241)
Total MET (min·week−1) 4516 (3043) 4511 (3163) 4518 (3017)
Eating behaviour
Cognitive restraint score 12 (4) 12 (4) 12 (4)
Disinhibition score 6 (4) 7 (4) 6 (3)∗
Hunger score 5 (4) 6 (4) 5 (4)
FTO rs99396909 genotype
AA 95 (18%) 18 (17%) 77 (18%)
AT 236 (45%) 40 (37%) 196 (47%)
TT 197 (37%) 49 (46%) 148 (35%)
Values for age, anthropometric characteristics, physical activity levels, and eating behaviour are mean (SD) and were analysed between sex using linear mixed
models. Values for central obesity and FTO rs99396909 genotype are frequency (%) andwere analysed between sex using chi-square tests. aCentral obesity was
deAned as a waist circumference >88 cm for women and >102 cm for men. bComplete physical activity data available for n� 408 (female: n� 83; male:
n� 325). ∗SigniAcant di9erence between females andmales (linear mixedmodel P< 0.05). ∗∗SigniAcant di9erence between females andmales (chi-square test
P< 0.05).
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sent from and returned to FitnessGenes Ltd. by post. DNA
was extracted by LGC Genomics (Hertfordshire, UK) and
genotyped using a KASP™ genotyping assay for FTO
rs9939609 SNP. Genotype frequency of FTO rs9939609 SNP
was assessed using a goodness-of-At chi-square test and did
not deviate from Hardy–Weinberg equilibrium (AA� 95,
AT� 236, TT�197; P � 0.10).
2.3. Collection of Demographic and Anthropometric
Data. Participants self-reported their sex, age, stature, body
mass, waist circumference, country of birth, and ethnicity
using an online questionnaire. Sex, age, and ethnicity were
conArmed by cross-referencing against customer in-
formation held by FitnessGenes Ltd. Participant stature,
body mass, and waist circumference were used to calculate
BMI and waist-to-height ratio (Table 1). Central obesity was
calculated as the percentage of participants that exceeded
previously deAned thresholds for waist circumference
(females> 88 cm and males> 102 cm) [24].
2.4. Physical Activity Levels. Physical activity levels were
measured using the validated short format of the In-
ternational Physical Activity Questionnaire (IPAQ) [25].
+e IPAQ assesses the frequency and duration of walking,
and moderate- and vigorous-intensity physical activities
performed in bouts lasting 10 minutes or more during the
previous seven days. Total physical activity (MET (metabolic
equivalent), minutes per week) was estimated bymultiplying
the number of minutes reported in each activity level by the
speciAc MET score for that activity (walking: 3.3, moderate
intensity: 4.0, and vigorous intensity: 8.0 METs), and par-
ticipants were classiAed in one of the three physical activity
levels: low, moderate, or high (http://www.ipaq.ki.se).
2.5. Eating Behaviour. Eating behaviour was assessed using
the validated 51-item +ree-Factor Eating Questionnaire
(TFEQ) to measure the dietary restraint (21 items, Cron-
bach’s α 0.788), disinhibition (16 items, Cronbach’s α 0.745),
and hunger (14 items, Cronbach’s α 0.761) [26]. All TFEQ
items were coded with either 0 or 1 point and summed
within each domain. Higher scores within each domain were
indicative of higher restrained eating, disinhibited eating, or
a predisposition to hunger.
2.6. Statistical Analyses. Data were analysed using the IBM
SPSS Statistics Software for Windows Version 21 (IBM, New
York). Between-sex di9erences in participant characteristics
were examined using linear mixed models with one Axed
factor (sex). Linear mixed models, adjusted for age and sex,
were used to examine between-genotype di9erences in
obesity-related parameters, physical activity levels, and
eating behaviour with one Axed factor (FTO rs99396909
genotype). Between-genotype di9erences in all outcome
measures were analysed using the additive genotype model
(AA versus AT versus TT). Statistical power for this model
was estimated using the CaTS Genome Power Calculator
methods [27]. +is method calculates the probability of
outcomes per genotype, and thus the statistical power of the
study based on the disease allele frequencies and prevalence
of the disease within a population (i.e., the probability that
a randomly sampled individual is obese or has a higher BMI)
[27]. +e calculation was performed using the genotype
relative risk (GRR) for the additive genotype model
(GRR� f1/f0, where f0 and f1 are the probabilities of being
a9ected for individuals with 0 or 1 risk allele, resp.). For this
study, a power of over 0.97 for a one-stage study was re-
ported with a signiAcance of 0.005. Where signiAcant main
e9ects were found in the additive genotype model, post hoc
analysis was performed using Holm–Bonferroni correction
for multiple comparisons [28]. Exploratory analysis was also
conducted to analyse potential between-genotype di9er-
ences in all outcome measures using the dominant model
(risk allele carriers (AA/AT) versus homozygous nonrisk
genotype (TT)) and the recessive model (nonrisk allele
carriers (AT/TT) versus homozygous risk genotype (AA)).
Di9erences in categorical variables (central obesity and FTO
genotype frequency) between sex and/or FTO genotype
groups were analysed using chi-square tests. E9ect sizes are
used to supplement important Andings. An e9ect size of 0.2
was considered the minimum important di9erence in all
outcome measures, 0.5 was moderate, and 0.8 was large [29].
Continuous variables are presented as mean (SD) and
categorical variables as frequency (%). Statistical signiAcance
was accepted as P< 0.05.
3. Results
3.1. Participant Characteristics. On average, participants
reported engaging in a total of 4516 (3043) METminutes of
activity per week, and the majority of participants were
classiAed in the high physical activity category of the IPAQ
(high 75.2%, moderate 19.4%, and low 5.4%), conArming the
cohort were physically active (Table 1). Moreover, partici-
pants reported engaging in, on average, 3366
METmin·week−1 of moderate- to vigorous-intensity phys-
ical activity (Table 1), which is considerably higher than the
average levels of moderate- to vigorous-intensity physical
activity reported in adults across European countries (range
45–960 METmin·week−1) [30]. Participants reported the
following reasons for engaging in physical activity: muscle
building training n� 276 (52%); fat loss training n� 168
(32%); strength training n � 40 (8%); power training n � 20
(4%); endurance training n � 17 (3%); and no response
n � 7 (1%).
Females were signiAcantly older (ES� 0.24, P � 0.02),
had a higher frequency of central obesity (odds ratio� 6.31,
P< 0.001), and exhibited higher TFEQ disinhibition scores
(ES� 0.42, P< 0.001) compared with males (Table 1). Body
mass, BMI, and waist circumference were signiAcantly lower
in females than males (all ES≥ 0.38, P≤ 0.001), but waist-to-
height ratio was similar between the sexes (ES� 0.09,
P � 0.40) (Table 1). No signiAcant di9erences were seen
between the sexes for any measure of physical activity (all
ES≤ 0.13, P≥ 0.28) or FTO genotype frequency (P � 0.12)
(Table 1).
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Figure 1: Box plots and analysis of the e9ect of FTO rs9939609 gene variant on obesity-related parameters. (a, b) Body mass index (BMI);
(c, d) waist circumference (WC); (e, f) waist-to-height ratio (WHtR). (a, c, e) female; (b, d, f) male. Females: n� 107 (AA� 18, AT� 40, and
TT� 49). Males: n� 421 (AA� 77, AT�196, and TT�148). +e line within box represents the median, while the lower and upper box lines
represent the interquartile range (1st and 3rd quartiles). +e whiskers represent the minimum and maximum observations. Linear mixed
models, adjusted for age and sex, were used to examine between-genotype di9erences. No signiAcant di9erences were seen in obesity-related
parameters between FTO rs9939609 genotypes.
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3.2. FTO rs9939609 Genotype and Obesity-Related
Parameters. Obesity-related parameters in men and
women carrying di9erent risk variants of FTO rs9939609
SNP are displayed in Figure 1 and Table 2. Linear mixed
models for the additive genotype model revealed no sig-
niAcant di9erences in body mass, BMI, waist circumference,
or waist-to-height ratio across FTO rs9939609 genotype
groups (all P≥ 0.66; Table 2). +e minor allele frequency is
analogous with that expected (0.4, A), suggesting this is not
due to an unrepresentative population. Exploratory analysis
revealed no signiAcant di9erences in obesity-related pa-
rameters when analysed in dominant (all ES≤ 0.13, P≥ 0.37)
or recessive (all ES≤ 0.08, P≥ 0.68) allele models (Supple-
mentary Table 1).
3.3. FTO rs9939609 Genotype and Physical Activity
Levels. Complete physical activity data were available for
408 participants (AA n� 74, AT n� 177, TT n� 157; female:
n� 83 and male: n� 325). +e physical activity levels in
men and women carrying di9erent risk variants of FTO
rs9939609 SNP are displayed in Table 3. Linear mixed
models for the additive genotype model revealed no sig-
niAcant di9erences in physical activity levels across FTO
rs9939609 genotype groups (all P≥ 0.10). In the exploratory
analysis, the dominant allele model revealed total MET
minutes per week (ES� 0.22, P � 0.03, Supplementary
Table 2) and a tendency for vigorous METminutes per week
(ES� 0.19, P � 0.08) to be higher in A allele carriers
(AA/AT) than nonrisk allele carriers (TT). No signiAcant
di9erences in moderate or walking MET minutes per week
were identiAed in the dominant allele model (AA/AT versus
TT) (all ES≤ 0.13, P≥ 0.17; Supplementary Table 2). +e
recessive allele model (AT/TT versus AA) revealed no sig-
niAcant di9erences in physical activity levels between FTO
genotype groups (all ES≤ 0.11, P≥ 0.28; Supplementary
Table 2).
3.4. FTO rs9939609 Genotype and Eating Behaviours. Eating
behaviours in men and women carrying di9erent risk var-
iants of FTO rs9939609 SNP are displayed in Table 4. Linear
Table 2: Obesity-related parameters in men and women carrying di9erent risk variants of the FTO rs9939609 single nucleotide
polymorphism.
Characteristic
FTO rs9939609 genotype
Model 1a: genotype P value
AA AT TT
Body mass (kg) 83.7 (14.7) 84.4 (16.5) 82.0 (17.2) 0.69
Body mass index (kg·m−2) 26.8 (3.9) 26.8 (4.3) 26.4 (4.3) 0.66
Waist circumference (cm) 85.2 (9.4) 84.9 (10.4) 84.1 (11.0) 0.87
Waist-to-height ratio 0.48 (0.05) 0.48 (0.06) 0.48 (0.06) 0.85
Central obesityb 6 (7%) 16 (7%) 15 (8%) 0.92
Values for body mass, body mass index, waist circumference, and waist-to-height ratio represent mean (SD) and were analysed using linear mixed models
adjusted for age and sex. Values for central obesity represent frequency (%) and were analysed using chi-square tests. ES, e9ect size (body mass, body mass
index, waist circumference, and waist-to-height ratio); OR, odds ratio (central obesity). aModel 1: additive genotype model (AA versus AT versus TT).
bCentral obesity was deAned as a waist circumference> 88 cm for women and> 102 cm for men.
Table 3: Physical activity levels in men and women carrying di9erent risk variants of the FTO rs9939609 single nucleotide polymorphism.
Characteristic
FTO rs9939609 genotype
Model 1a: genotype P value
AA (n� 74) AT (n� 177) TT (n� 157)
Vigorous MET (min·week−1) 2808 (1966) 2751 (1903) 2407 (1876) 0.19
Moderate MET (min·week−1) 726 (1069) 816 (1127) 654 (874) 0.41
Walking MET (min·week−1) 1240 (1242) 1207 (1345) 1043 (1192) 0.34
Total MET (min·week−1) 4774 (3125) 4774 (3193) 4104 (2795) 0.10
Values are mean (SD) for n� 408. Comparisons were made using linear mixed models adjusted for age and sex. ES, e9ect size. aModel 1: additive genotype
model (AA versus AT versus TT).
Table 4: Eating behaviour in men and women carrying di9erent risk variants of the FTO rs9939609 single nucleotide polymorphism.
Characteristic
FTO rs9939609 genotype
Model 1a: genotype P value
AA (n� 95) AT (n� 236) TT (n� 197)
Cognitive restraint score 13 (4) 12 (4) 11 (4) 0.03∗
Disinhibition score 6 (3) 7 (4) 6 (4) 0.38
Hunger score 5 (3) 5 (4) 5 (4) 0.92
Values are mean (SD) for n� 528. Comparisons were made using linear mixed models adjusted for age and sex. ES, e9ect size. aModel 1: additive genotype
model (AA versus AT versus TT). ∗SigniAcant di9erence between AA and TT FTO rs9939609 genotype (linear mixed model P< 0.05 after Holm–Bonferroni
correction).
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mixed models for the additive genotype model identiAed
a signiAcant main e9ect for cognitive restraint score across
FTO genotype groups (P � 0.03). Post hoc analysis of
between-group di9erences revealed that the cognitive re-
straint score was higher in homozygous A allele carriers than
AT (ES� 0.25, P � 0.07) and TT (ES� 0.33, P � 0.03) ge-
notypes; AT and TT genotypes were similar (ES� 0.06,
P � 0.49). No di9erences in disinhibition or hunger scores
were seen across FTO genotype groups (both P≥ 0.38).
In the exploratory analysis, the dominant allele model
(AA/AT versus TT) revealed no signiAcant di9erences in
cognitive restraint, disinhibition, or hunger scores between
FTO genotype groups (all ES≤ 0.14, P≥ 0.12). +e recessive
allele model was consistent with that seen in the additive
genotype model, in that the cognitive restraint score was
higher in homozygous A allele carriers (AA) than T allele
carriers (AT/TT) (ES � 0.28, P � 0.01; Supplementary
Table 3). No signiAcant di9erences in disinhibition or
hunger scores were identiAed in the recessive allele model
(all ES ≤ 0.08, P≥ 0.60; Supplementary Table 3).
4. Discussion
+e primary Anding from the present study was that obesity-
related parameters were not di9erent in physically active
individuals carrying di9erent risk variants of FTO rs9939609
SNP. Furthermore, FTO rs9939609 homozygous A allele
carriers exhibited higher cognitive restraint than nonrisk
allele carriers, and exploratory analysis also showed higher
levels of physical activity in A allele carriers compared with
nonrisk allele carriers.
+e consensus of evidence suggests that FTO risk alleles
are associated with elevated body weight across di9erent
ages and populations, with each minor risk allele increasing
BMI and obesity risk by 0.25–0.39 kg·m−2 and 1.18–1.27 fold,
respectively [9]. However, the most extensively studied
rs9939609 SNP had no inFuence on obesity-related pa-
rameters in the current study. +e participants in our cohort
were physically active, and the average levels of reported
total and moderate- to vigorous-intensity physical activity
were considerably higher in comparison with both the
general population [30] and individuals in previous FTO
studies [19–23]. Several studies have demonstrated, through
self-reported questionnaires [31, 32] and objective physical
activity devices [19, 33], that obesity-related traits associated
with FTO risk alleles are attenuated in individuals with
higher physical activity levels. +erefore, it is possible that
the high physical activity levels within our cohort may have
diminished any di9erences in obesity-related parameters
between FTO rs9939609 genotypes. Intriguingly, despite
being a highly active group when taken as a whole, the
exploratory analysis using the dominant model demon-
strated that individuals with the A allele reported higher total
and vigorous physical activity levels compared with TT
individuals. It is possible, therefore, that this di9erence in
physical activity patterns between FTO genotypes may
further o9set the adiposity-increasing e9ect of FTO within
this cohort, but additional work is required to examine this
systematically. Nonetheless, this elevation in activity was
small, and these di9erences in physical activity levels be-
tween FTO genotypes conFict with previous studies sug-
gesting that FTO genotype does not impact on physical
activity levels [7, 31]. Contradictions between the current
study and other evidence may be due to the high levels of
intensive physical activity of individuals within the current
study. Although Berentzen et al. [16] reported no e9ect of the
FTO variant on physical activity in individuals classiAed by
the authors as highly active (more than 4 h moderate
physical activity a week), there is a lack of studies that have
examined the e9ect of FTO genotype on activity levels in
cohorts with even greater levels of physical activity. Con-
sequently, further studies, including longitudinal in-
vestigations, are required to examine FTO-mediated
di9erences in physical activity among individuals with
varying activity status. In addition, given that much of the
data on FTO-mediated di9erences in physical activity levels
are reliant on self-reported questionnaire data, additional
scientiAc enquiry using objective physical activity measures,
such as accelerometers, is required.
It has been postulated that FTO-mediated predisposition
to weight gain and obesity may be modiAed by dietary
behaviours. Research suggests that FTO may play a signiA-
cant role in the regulation of satiety and food intake [10, 11].
Furthermore, it has been reported in previous observational
studies that the risk variant of FTO is associated with lower
cognitive restraint and higher disinhibition and hunger,
which may be indicative of poorer eating behaviours
[34, 35]. +e present study extends these Andings by
demonstrating that physically active individuals homozy-
gous for FTO rs9939609 risk allele display higher cognitive
restraint but similar disinhibition and hunger scores com-
pared with nonrisk allele carriers. +e potential beneAt of
cognitive restraint on the propensity to body weight changes
is highlighted by studies demonstrating a negative associ-
ation between cognitive restraint and markers of adiposity
(e.g., body mass and BMI) [36, 37]. However, such asso-
ciations are not reported universally [38], and cognitive
restraint tends to be higher in overweight than in healthy
weight individuals [39]. Additionally, disinhibition has been
proposed as a stronger predictor of BMI [40]. Nevertheless,
increased dietary restraint during weight loss has been
identiAed as a signiAcant predictor of successful weight loss
maintenance [41]. +erefore, it is possible that the higher
cognitive restraint observed in FTO risk allele carriers in the
present study may o9set FTO-mediated obesity risk in
physically active individuals; but further work is required to
conArm this chronically.
+e current study is not without limitations. +e ob-
servations in the present study are limited by the cross-
sectional design, which precludes the ability to establish
causality. Future longitudinal studies are required to es-
tablish systematically whether higher physical activity levels
and cognitive restraint may diminish FTO-mediated pre-
disposition to weight gain. In addition, the anthropometric,
physical activity, and eating behaviour data were self-
measured and self-reported using an online survey, which
may have led to problems with participant measurement
error, recall, and bias. Additional work is therefore required
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using more direct and objective measures. Furthermore, one
of the primary measures of body fatness in the present study
is BMI. Despite its frequent use in large-scale population
studies, BMI does not take into account di9erences between
fat and fat-free mass such as muscle and bone [42]. Given the
current cohort reported high levels of total activity, with the
majority indicating that their primary Atness goal was
muscle building (52%), it is possible that variations in body
mass (and hence BMI) could be largely due to higher muscle
mass. +is may explain why the average BMI among in-
dividuals in the current data set falls within the overweight
category. Consequently, future studies using more direct
measures of body adiposity are required to replicate the
current study’s Andings. Finally, statistical power was lim-
ited in the dominant and recessive models analysed in this
paper. However, the results from these exploratory models
allow for preliminary inferences that may guide a larger
population-based study.
5. Conclusion
Within a physically active cohort, risk allele carriers of FTO
rs9939609 exhibited greater physical activity levels and
cognitive restraint than nonrisk allele carriers despite
demonstrating similar adiposity-related measures. Future
studies with repeated and objective measurements are re-
quired to further investigate physical activity and dietary
behaviours that underscore the e9ects of FTO on obesity
risk.
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